Tendinopathy: Disorders that are causes by overuse of tendons.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
595 |
4. Check minimum number of eventsNone |
595 |
5. Include endpointsNone |
595 |
6. Filter based on genotype QC (FinnGen only) |
595 |
Control definitions (FinnGen only)
- Control exclude
- M13_DORSOPATHY
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M76
- Name in latin
- Tendinitis peronea
Similar endpoints
↥List of similar endpoints to
Peroneal tendinitis
based on the number of shared cases.
Similar with more cases:
- Enthesopathies of lower limb, excluding foot
- Soft tissue disorders
- Dorsopathies
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3180 | 2043 | 1125 |
| Only index persons | 3138 | 2032 | 1106 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.06 | 0.03 |
| Only index persons | 0.06 | 0.07 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 51.56 | 51.89 | 50.97 |
| Only index persons | 51.56 | 51.87 | 50.97 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 595 | 431 | 164 |
| Unadjusted period prevalence (%) | 0.13 | 0.15 | 0.07 |
| Median age at first event (years) | 54.44 | 53.57 | 56.73 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 502
- Matched controls
- 5019
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M76.7
ICD-10 Finland
Peroneal tendinitis
+∞
323.0
502
6
NHL50
NOMESCO Finland
Tenolysis or tenosynovectomy of foot
283.9
73.5
73
*
NHL30
NOMESCO Finland
Suture or reinsertion of tendon of foot
142.0
70.0
73
6
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
34.0
68.8
90
32
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
39.4
63.4
80
24
L16
ICPC
Ankle symptom/complaint
8.0
53.7
134
219
M01AH05
ATC
etoricoxib; oral
4.7
51.9
392
2160
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
26.0
50.0
70
31
M79.6
ICD-10 Finland
Pain in limb
4.1
46.3
256
1015
M76.6
ICD-10 Finland
Achilles tendinitis
16.0
42.9
71
51
M25.5
ICD-10 Finland
Pain in joint
3.9
40.2
218
823
M54.5
ICD-10 Finland
Low back pain
3.9
36.7
188
664
WX320
NOMESCO Finland
Spinalanesthesy
4.1
36.4
176
590
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
28.4
36.2
49
19
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
24.5
36.1
51
23
M48.0
ICD-10 Finland
Spinal stenosis
35.2
35.1
45
14
R4110
NOMESCO Finland
Physiotherapy
3.7
34.3
193
729
N03AX16
ATC
pregabalin; oral
4.4
34.2
145
427
N02AX02
ATC
tramadol; systemic, rectal
3.4
33.8
233
1030
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.2
33.6
280
1418
N02AJ06
ATC
codeine and paracetamol; systemic
3.2
32.2
234
1063
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
91.1
31.1
34
*
M54.4
ICD-10 Finland
Lumbago with sciatica
6.1
30.8
90
174
M01AB05
ATC
diclofenac; systemic, rectal
3.3
30.7
387
2538
N03AX12
ATC
gabapentin; oral
5.6
29.1
91
191
ZXA00
NOMESCO Finland
Right side
3.4
28.3
172
671
M03BX02
ATC
tizanidine; oral
2.8
24.7
357
2358
ZXE10
NOMESCO Finland
More than one and less than three hours
2.8
24.1
223
1126
M03BC01
ATC
orphenadrine (citrate); systemic
3.2
23.9
155
621
Z3226
NOMESCO Finland
Physiotherapist
3.5
23.6
128
450
M77.4
ICD-10 Finland
Metatarsalgia
6.1
23.5
67
124
ZXD10
NOMESCO Finland
Scheduled procedure
2.7
23.4
238
1267
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
+∞
23.1
22
*
S93.4
ICD-10 Finland
Sprain and strain of ankle
4.3
23.0
92
248
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
8.8
22.5
49
61
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
5.7
22.2
66
129
M17.1
ICD-10 Finland
Other primary gonarthrosis
3.3
22.1
126
457
A02BC02
ATC
pantoprazole; systemic
2.6
22.1
346
2312
NHL16
NOMESCO Finland
Tenolysis or tenosynovectomy of achilles tendon
120.3
21.8
23
*
M01AE02
ATC
naproxen; oral, rectal
2.5
21.4
326
2127
M01AH01
ATC
celecoxib; oral (coxibs)
3.4
21.3
116
405
L17
ICPC
Foot/toe symptom/complaint
2.9
21.2
155
666
M75.1
ICD-10 Finland
Rotator cuff syndrome
3.0
20.5
136
546
X59
ICD-10 Finland
Exposure to unspecified factor
3.2
20.5
122
455
ZXA05
NOMESCO Finland
Left side
2.8
19.5
149
651
M66.4
ICD-10 Finland
Spontaneous rupture of other tendons
48.0
19.4
23
5
M19.0
ICD-10 Finland
Primary arthrosis of other joints
4.8
18.8
65
150
X58
ICD-10 Finland
Exposure to other specified factors
3.5
18.7
94
307
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
15.9
18.7
30
20
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
54.6
18.1
21
*
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
+∞
17.8
17
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
7.2
17.2
42
63
N02BE01
ATC
paracetamol; systemic, rectal
2.9
17.1
437
3515
B01AB05
ATC
enoxaparin; parenteral
2.5
17.1
169
848
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
16.6
145
678
M65.8
ICD-10 Finland
Other synovitis and tenosynovitis
10.3
16.4
32
33
M70.6
ICD-10 Finland
Trochanteric bursitis
3.8
16.3
72
210
TQW40
NOMESCO Finland
Remowal of suture of skin
4.4
16.3
61
153
M54.1
ICD-10 Finland
Radiculopathy
15.2
16.0
26
18
M54.9
ICD-10 Finland
Dorsalgia, unspecified
5.2
15.8
50
105
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
4.2
15.6
61
159
M53.1
ICD-10 Finland
Cervicobrachial syndrome
4.0
15.4
64
177
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
4.7
15.4
53
122
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.8
15.4
69
204
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.3
15.3
192
1075
L03
ICPC
Low back symptom/complaint
2.8
14.9
109
457
M76.8
ICD-10 Finland
Other enthesopathies of lower limb, excluding foot
17.1
14.9
23
14
M54.3
ICD-10 Finland
Sciatica
8.1
14.9
33
43
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
+∞
14.7
14
*
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
+∞
14.7
14
*
Z2221
NOMESCO Finland
Medical doctor
2.3
14.6
169
905
R03AC02
ATC
salbutamol; inhalant
2.1
14.5
280
1883
NHL99
NOMESCO Finland
Other operation on muscle or tendon of ankle or foot
28.1
14.4
19
7
ZXE00
NOMESCO Finland
One hour or less
2.1
14.2
225
1387
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
43.8
14.2
17
*
M02AA07
ATC
piroxicam; topical
2.2
13.8
187
1072
M77.1
ICD-10 Finland
Lateral epicondylitis
3.9
13.7
57
158
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
+∞
13.6
13
*
M01AC06
ATC
meloxicam; systemic, rectal
2.1
13.6
195
1146
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
143.7
13.5
14
*
A02BC05
ATC
esomeprazole; systemic
2.1
13.4
210
1275
M02AA10
ATC
ketoprofen; topical
2.8
13.2
90
359
WX110
NOMESCO Finland
Local anesthesy
2.1
13.0
356
2701
L28
ICPC
Limited function/disability (L)
3.2
13.0
72
249
M01AE03
ATC
ketoprofen; systemic, rectal
2.1
12.9
189
1114
N06AX21
ATC
duloxetine; oral
3.4
12.8
64
206
M24.2
ICD-10 Finland
Disorder of ligament
9.7
12.6
25
27
M79.1
ICD-10 Finland
Myalgia
3.0
12.6
75
274
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.7
12.4
91
377
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
8.1
12.3
27
35
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
5.5
12.2
36
70
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
4.3
12.0
45
113
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
4.1
12.0
47
123
NHL68
NOMESCO Finland
Tenodesis, shortening or lengthening of tendon of foot
13.0
11.7
20
16
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.3
11.6
43
107
M03BC51
ATC
orphenadrine, combinations; systemic
2.1
11.5
159
904
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.0
11.5
69
253
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
11.4
140
757
Z3231
NOMESCO Finland
Registered nurse
2.2
11.4
134
708
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
3.1
11.3
65
232
R51
ICD-10 Finland
Headache
4.9
11.2
36
78
M01AE01
ATC
ibuprofen; systemic, rectal
2.8
11.1
464
4070
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
14.3
11.0
18
13
R51.80
ICD-10 Finland
Headache
2.7
11.0
78
318
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
12.3
10.9
19
16
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.8
10.9
74
294
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.7
10.8
77
315
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
2.9
10.8
67
252
L86
ICPC
Back syndrome with radiating pain
6.6
10.8
27
43
R01AD09
ATC
mometasone; nasal
1.9
10.7
246
1690
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
10.7
142
790
L15
ICPC
Knee symptom/complaint
2.3
10.7
106
517
S96.8
ICD-10 Finland
Injury of other muscles and tendons at ankle and foot level
61.3
10.7
12
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.6
10.7
36
82
A02BC03
ATC
lansoprazole; oral
2.1
10.7
142
792
J01FA10
ATC
azithromycin; systemic
1.9
10.6
317
2387
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
7.1
10.5
25
37
9211
FHL
Exploration or removal of diskusprolapse
+∞
10.4
10
*
S18
ICPC
Laceration/cut
1.9
10.4
192
1216
TNH31
NOMESCO Finland
Prefabricated orthosis, ankle or foot
10.9
10.4
19
18
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
4.6
10.3
35
80
M13.9
ICD-10 Finland
Arthritis, unspecified
3.3
10.0
50
162
M01AX17
ATC
nimesulide; oral
2.2
9.9
117
615
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
9.9
123
664
M50.3
ICD-10 Finland
Other cervical disc degeneration
26.6
9.9
13
5
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.6
9.8
44
131
Z71.8
ICD-10 Finland
Other specified counselling
2.1
9.8
124
675
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
9.6
229
1573
M54.2
ICD-10 Finland
Cervicalgia
4.6
9.5
32
73
H02AB06
ATC
prednisolone; systemic
1.8
9.5
221
1506
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.8
9.5
40
113
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
2.9
9.5
59
222
J01CA04
ATC
amoxicillin; systemic
2.0
9.4
403
3365
M54.6
ICD-10 Finland
Pain in thoracic spine
4.2
9.4
35
88
Q66.7
ICD-10 Finland
Pes cavus
30.7
9.4
12
*
M47.9
ICD-10 Finland
Spondylosis, unspecified
30.7
9.4
12
*
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.7
9.4
65
259
M01AH02
ATC
rofecoxib; oral
2.7
9.4
65
260
ZXD20
NOMESCO Finland
Day surgery
2.4
9.3
82
375
WX002
NOMESCO Finland
Sedation and analgesia
2.2
9.3
102
519
R06AE07
ATC
cetirizine; oral
1.8
9.2
231
1608
L08
ICPC
Shoulder symptom/complaint
2.3
9.2
90
432
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.3
9.2
90
433
R52.9
ICD-10 Finland
Pain, unspecified
3.2
9.2
47
155
NH1AA
SPAT
NA
6.1
9.2
24
41
J01AA02
ATC
doxycycline; systemic
1.9
9.1
392
3252
NH1BG
SPAT
NA
11.8
9.1
16
14
M66.5
ICD-10 Finland
Spontaneous rupture of unspecified tendon
37.4
9.0
11
*
M54
ICD-10 Finland
Dorsalgia
2.9
9.0
56
211
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
4.5
9.0
31
73
J01DB01
ATC
cefalexin; oral
2.0
8.9
412
3495
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
8.8
266
1956
SPAT1212
SPAT
Extensive examination of musculoskeletal system
3.4
8.8
42
132
M53.0
ICD-10 Finland
Cervicocranial syndrome
3.0
8.7
50
178
Z50.1
ICD-10 Finland
Other physical therapy
4.6
8.7
29
66
M76.9
ICD-10 Finland
Enthesopathy of lower limb, unspecified
11.9
8.6
15
13
M01AB55
ATC
diclofenac, combinations; oral
3.6
8.6
38
112
M25.2
ICD-10 Finland
Flail joint
10.3
8.6
16
16
NHA30
NOMESCO Finland
Exploration of joint of ankle or foot, arthroscopic
20.4
8.5
12
6
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
5.0
8.5
26
54
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
+∞
8.4
8
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
9.7
8.3
16
17
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
8.3
110
606
M65.9
ICD-10 Finland
Synovitis and tenosynovitis, unspecified
5.3
8.3
24
47
N02AA05
ATC
oxycodone; systemic
2.7
8.3
55
215
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
2.9
8.2
51
191
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
4.0
8.1
31
81
M67.8
ICD-10 Finland
Other specified disorders of synovium and tendon
9.1
8.1
16
18
J31.0
ICD-10 Finland
Chronic rhinitis
3.2
8.1
42
141
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
8.1
74
346
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
3.7
8.0
34
97
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
8.0
110
613
G44.2
ICD-10 Finland
Tension-type headache
2.4
8.0
67
299
S93.2
ICD-10 Finland
Rupture of ligaments at ankle and foot level
7.4
8.0
18
25
WX402
NOMESCO Finland
General anaesthesia
2.1
8.0
93
484
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.0
8.0
118
675
R01AD12
ATC
fluticasone furoate; nasal
1.8
7.9
162
1041
M43.1
ICD-10 Finland
Spondylolisthesis
11.0
7.8
14
13
R03DC03
ATC
montelukast; oral
2.1
7.7
89
460
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.0
7.6
114
656
R60.0
ICD-10 Finland
Localized oedema
2.7
7.6
51
199
ZA7.0
ICD-10 Finland
Ankle and foot
9.1
7.6
15
17
R06AX22
ATC
ebastine; oral
2.0
7.5
99
545
J45.9
ICD-10 Finland
Asthma, unspecified
2.2
7.4
81
409
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
6.1
7.4
19
32
R42
ICD-10 Finland
Dizziness and giddiness
2.1
7.4
87
453
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
7.4
177
1193
N05CF02
ATC
zolpidem; oral
2.0
7.4
98
536
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
11.1
7.3
13
12
R74
ICPC
Upper respiratory infection acute
1.8
7.3
144
910
N06AA09
ATC
amitriptyline; systemic
2.7
7.3
48
188
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.7
7.3
48
188
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
+∞
7.3
7
*
ABC26
NOMESCO Finland
Open discectomy of lumbar spine
+∞
7.3
7
*
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
5.9
7.3
19
33
R07.4
ICD-10 Finland
Chest pain, unspecified
2.0
7.3
106
603
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
16.0
7.3
11
7
NHE15
NOMESCO Finland
Suture or reinsertion of ligament of ankle
16.0
7.3
11
7
R03BA02
ATC
budesonide; inhalant
2.1
7.2
91
487
M45
ICD-10 Finland
Ankylosing spondylitis
30.5
7.2
9
*
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
6.7
7.2
17
26
ZXA10
NOMESCO Finland
Bilateral
2.1
7.2
85
445
G47.3
ICD-10 Finland
Sleep apnoea
2.0
7.2
95
523
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
7.1
116
688
S29
ICPC
Skin symptom/complaint other
2.1
6.9
79
406
R23.8
ICD-10 Finland
Other and unspecified skin changes
2.1
6.9
77
393
L13
ICPC
Hip symptom/complaint
2.3
6.9
66
314
R52.2
ICD-10 Finland
Other chronic pain
5.4
6.8
19
36
R05
ICD-10 Finland
Cough
2.0
6.8
89
486
S86.3
ICD-10 Finland
Injury of muscle(s) and tendon(s) of peroneal muscle group at lower leg level
9.5
6.8
13
14
NH1AD
NOMESCO Finland
Ankle and foot CT
5.8
6.8
18
32
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.4
6.8
31
95
H01
ICPC
Ear pain/earache
2.5
6.8
51
216
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
6.8
54
236
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.6
6.8
271
2096
W19
ICD-10 Finland
Unspecified fall
2.7
6.7
46
182
G57.8
ICD-10 Finland
Other mononeuropathies of lower limb
22.9
6.7
9
*
M77.0
ICD-10 Finland
Medial epicondylitis
5.3
6.7
19
37
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
3.2
6.7
33
108
M84.3
ICD-10 Finland
Stress fracture, not elsewhere classified
8.0
6.7
14
18
ACC51
NOMESCO Finland
Release of median nerve
2.8
6.7
40
149
N06AX11
ATC
mirtazapine; oral
1.7
6.6
148
969
NHG26
NOMESCO Finland
Fusion between bones of ankle or ankle and foot
10.2
6.6
12
12
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.0
6.6
83
447
P01AB01
ATC
metronidazole; oral, rectal
1.7
6.5
202
1452
S86.0
ICD-10 Finland
Injury of Achilles tendon
5.4
6.5
18
34
M65.4
ICD-10 Finland
Radial styloid tenosynovitis [de Quervain]
5.4
6.5
18
34
S01GX01
ATC
cromoglicic acid; ophthalmic
1.9
6.5
107
636
L01
ICPC
Neck symptom/complaint
2.2
6.5
62
297
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
3.4
6.4
29
89
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
6.4
63
304
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
6.7
6.4
15
23
XA402
NOMESCO Finland
ENMG
6.1
6.3
16
27
M65
ICD-10 Finland
Synovitis and tenosynovitis
6.1
6.3
16
27
SPAT1153
SPAT
Removal of sutures
1.8
6.3
131
840
NGL58
NOMESCO Finland
Tenolysis or tenosynovectomy of knee or lower leg
+∞
6.3
6
*
NGL38
NOMESCO Finland
Suture or reinsertion of tendon of knee or lower leg
+∞
6.3
6
*
ABC30
NOMESCO Finland
Decompression of cervical nerve roots
+∞
6.3
6
*
A02BC01
ATC
omeprazole; systemic
1.8
6.2
116
717
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
3.0
6.2
33
114
TNH33
NOMESCO Finland
Custom moulded brace, ankle or foot
5.5
6.2
17
32
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.5
6.2
49
212
D07AB02
ATC
hydrocortisone butyrate; topical
1.7
6.1
137
896
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
2.2
6.1
64
319
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
3.8
6.1
24
66
S83.2
ICD-10 Finland
Tear of meniscus, current
2.8
6.1
37
140
G54.0
ICD-10 Finland
Brachial plexus disorders
5.7
6.0
16
29
A02BA02
ATC
ranitidine; systemic
1.9
6.0
86
482
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
181
755
3.01
30.99
1.4
1.2
u/ml
12.4
12.1
0.02
59
314
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
173
794
2.66
23.93
1.4
1.2
iu/ml
23.4
29.3
0.33
51
267
(3026493) Urate [Moles/volume] in Serum or Plasma
204
1112
2.27
18.63
2.6
2.4
umol/l
323.7
4446.5
3.42
177
987
(3013707) Erythrocyte sedimentation rate by Westergren method
456
3437
2.40
18.24
4.5
3.5
mm/h
9.3
10.9
3.25
436
3181
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
137
640
2.48
17.69
2.7
2.4
e6/l
0.7
1.1
1.17
69
347
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
189
1023
2.24
17.36
2.0
1.7
mg/l
1.0
1.0
0.10
149
763
(3030467) Casts [#/volume] in Urine by Automated count
198
1106
2.18
16.72
3.4
2.6
e6/l
0.2
0.4
2.18
151
814
(36304419) Bacteria [Presence] in Urine
196
1102
2.16
16.19
3.4
2.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
239
1460
2.06
15.77
6.0
5.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
236
1459
2.02
14.87
4.2
3.0
e6/l
24.6
113.3
2.18
165
1001
(3037522) Nuclear Ab [Titer] in Serum
127
620
2.33
14.63
1.3
1.3
titre
744.4
487.2
0.40
18
127
(3013650) Neutrophils [#/volume] in Blood by Automated count
367
2665
1.98
14.33
8.2
9.4
e9/l
4.1
3.9
0.54
315
2334
(3001604) Monocytes [#/volume] in Blood
325
2266
1.96
14.28
6.0
5.7
e9/l
0.6
0.6
0.88
284
1983
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
125
613
2.32
14.22
2.8
2.5
e6/l
2.1
3.0
0.60
59
322
(3018010) Neutrophils/100 leukocytes in Blood
318
2208
1.95
14.07
5.9
5.5
%
54.8
56.7
2.26
302
2085
(3006315) Basophils [#/volume] in Blood
325
2275
1.94
14.02
6.1
5.7
e9/l
0.0
0.0
0.14
284
1990
(3019198) Lymphocytes [#/volume] in Blood
331
2336
1.94
13.88
6.1
5.6
e9/l
2.2
1.9
0.68
295
2085
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
450
3536
2.12
13.79
7.9
7.0
u/l
75.2
76.7
0.50
431
3337
(3022096) Basophils/100 leukocytes in Blood
303
2081
1.93
13.74
6.0
5.7
%
0.7
0.7
0.10
285
1947
(3002030) Lymphocytes/100 leukocytes in Blood
318
2234
1.91
13.32
6.3
5.7
%
30.5
28.7
2.32
300
2094
(3019069) Monocytes/100 leukocytes in Blood
310
2166
1.90
13.14
6.5
5.9
%
8.4
8.4
0.02
294
2043
(3013115) Eosinophils [#/volume] in Blood
329
2350
1.89
12.96
6.5
6.0
e9/l
0.2
0.2
0.92
295
2090
(3006504) Eosinophils/100 leukocytes in Blood
308
2157
1.89
12.87
6.0
5.6
%
3.1
2.8
0.95
291
2019
(40758558) Short blood count panel - Blood
194
1173
1.97
12.61
5.9
6.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
400
3068
1.93
12.40
4.8
3.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
558
4882
3.30
12.30
15.8
10.8
mg/l
17.4
22.2
3.87
471
3703
(3002582) Erythrocytes [#/volume] in Urine
200
1231
1.94
12.29
3.6
2.6
e6/l
116.1
69.8
0.19
152
928
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
227
1460
1.90
12.19
3.7
2.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
160
925
2.00
11.71
3.5
2.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
48
163
3.12
11.26
1.1
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
290
2111
1.73
9.68
8.0
8.0
e9/l
0.0
0.0
0.76
226
1730
(40768797) Stomach Pathology biopsy report
109
588
2.05
9.50
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
153
928
1.87
9.47
1.6
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
285
2089
1.70
9.09
4.0
3.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
521
4557
2.15
8.89
5.4
4.5
mu/l
1.8
2.5
0.95
495
4229
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
254
1813
1.70
8.89
6.1
5.6
mmol/l
1.2
1.2
0.06
235
1663
(3000850) Epithelial cells [#/volume] in Urine
137
818
1.88
8.84
3.0
2.2
e6/l
6.3
7.6
0.39
122
721
(3013826) Glucose [Moles/volume] in Serum or Plasma
322
2454
1.68
8.74
4.5
4.2
mmol/l
6.5
6.6
0.81
306
2285
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
275
2015
1.68
8.65
6.7
6.6
mmol/l
1.2
1.2
0.61
248
1710
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
306
2309
1.67
8.57
5.8
6.2
umol/l
10.2
10.7
0.68
288
2213
(3044941) Cell count panel - Synovial fluid
22
53
4.27
8.52
1.5
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
24
62
3.99
8.50
1.5
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
103
566
1.99
8.48
2.2
2.3
ug/g
71.0
108.9
1.54
88
452
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
80
403
2.14
8.32
2.6
2.1
u/l
31.7
154.5
0.54
69
352
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
168
1088
1.76
8.23
1.2
1.2
u/ml
0.9
1.6
0.91
37
292
(3018418) pH of Serum or Plasma
181
1202
1.73
8.10
5.1
3.7
ph
7.4
7.4
0.45
25
246
(3007853) Bacteria identified in Skin by Aerobe culture
86
455
2.04
7.85
1.9
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
451
3826
1.74
7.60
4.4
3.9
pmol/l
14.4
14.6
0.55
423
3553
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
534
4782
2.14
7.49
13.3
9.9
ml/min/173m2
85.3
85.1
0.09
468
3911
(3000475) Leukocytes [#/volume] in Synovial fluid
27
84
3.32
7.33
1.7
1.5
e6/l
5624.7
18757.3
1.10
16
65
(3019550) Sodium [Moles/volume] in Serum or Plasma
552
5025
2.36
7.15
15.7
11.9
mmol/l
139.8
139.8
0.26
545
4881
(3023103) Potassium [Moles/volume] in Serum or Plasma
554
5052
2.40
7.13
16.1
11.9
mmol/l
3.9
3.9
0.96
547
4900
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
190
1316
1.65
7.11
3.1
2.3
u/l
60.8
56.1
0.80
174
1228
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
533
4806
2.05
6.77
4.7
4.0
mmol/l
5.9
5.8
0.15
498
4445
(3026782) Osmolality of Urine
125
784
1.75
6.71
3.0
2.2
mosm/kgh2o
509.4
560.9
1.89
107
678
(3000494) Fungus identified in Specimen by Culture
93
533
1.88
6.71
1.5
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
41
4.24
6.59
1.1
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
284
2196
1.56
6.57
5.0
4.1
estimate
0.0
0.0
0.50
44
409
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
16
37
4.42
6.53
1.4
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
221
1616
1.58
6.51
2.1
1.8
pmol/l
91.3
96.9
1.16
99
844
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
90
516
1.88
6.48
3.6
2.5
umol/l
4.7
7.5
2.73
80
445
(3007164) IgA [Mass/volume] in Serum or Plasma
144
955
1.67
6.27
1.7
1.5
g/l
2.1
2.3
0.82
73
601
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
45
201
2.34
6.25
1.4
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
283
2208
1.54
6.16
3.5
2.9
estimate
0.0
0.0
0.80
41
395
(3035350) Ketones [Presence] in Urine by Test strip
279
2173
1.53
6.10
3.5
2.9
estimate
0.0
0.0
0.00
43
404
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
182
1291
1.59
6.02
1.8
1.6
mmol/l
1.4
1.4
0.21
160
1097
(3014051) Protein [Presence] in Urine by Test strip
24
79
3.12
5.98
2.2
2.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
573
5366
2.83
5.87
11.5
9.0
u/l
27.2
26.0
0.99
561
5201
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
22
70
3.23
5.79
2.0
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
408
3477
1.55
5.70
3.9
3.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
151
1037
1.61
5.67
3.2
2.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
25
89
2.89
5.47
1.4
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
392
3330
1.52
5.40
3.3
3.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
32
131
2.52
5.38
2.8
3.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
39
3.92
5.29
1.1
1.3
nmol/l
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
588
5667
4.19
5.29
22.5
16.2
e9/l
260.0
257.6
0.40
581
5522
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
30
121
2.56
5.20
1.2
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
93
575
1.73
5.19
2.3
2.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
205
1535
1.51
5.18
6.1
6.9
inr
1.1
1.2
2.21
48
503
(3026361) Erythrocytes [#/volume] in Blood
588
5673
4.10
5.14
22.5
16.2
e12/l
4.5
4.5
0.10
580
5514
(3023368) Bacteria identified in Blood by Culture
142
983
1.58
5.11
4.1
4.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
69
392
1.86
5.10
2.7
2.0
nmol/l
360.5
380.0
0.34
64
365
(3010813) Leukocytes [#/volume] in Blood
588
5674
4.09
4.97
22.5
16.2
e9/l
6.7
6.5
0.75
581
5515
(3024561) Albumin [Mass/volume] in Serum or Plasma
227
1755
1.47
4.84
5.0
4.5
g/l
37.0
36.1
2.15
219
1650
(40768804) Tissue Pathology biopsy report
256
2031
1.46
4.75
2.1
2.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
93
590
1.68
4.72
1.7
1.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
111
741
1.61
4.62
2.9
3.1
ng/l
169.9
422.9
0.75
76
501
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
198
1501
1.48
4.62
3.1
2.9
ng/l
32.5
41.6
0.38
108
896
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
51
271
1.96
4.61
1.1
1.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
243
1917
1.45
4.61
2.6
2.1
nmol/l
77.3
75.6
0.48
221
1752
(3044640) Blood type and Crossmatch panel - Blood
186
1394
1.49
4.59
3.2
2.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
498
4520
1.62
4.57
5.5
4.9
mmol/mol
38.9
39.1
0.17
468
4231
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
57
316
1.89
4.55
2.6
2.4
au/ml
63.3
21.3
—
5
29
(3013139) Helicobacter pylori Ag [Presence] in Stool
59
331
1.87
4.55
1.4
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
30
130
2.38
4.50
1.4
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
207
1601
1.45
4.29
3.5
3.3
u/l
34.0
30.3
0.57
197
1535
(3035637) Corticotropin [Mass/volume] in Plasma
14
41
3.47
4.21
2.1
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
24
98
2.51
4.10
2.1
1.9
g/l
40.3
38.9
0.76
24
91
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
65
390
1.75
4.04
1.6
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
559
5273
1.99
4.03
12.7
10.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
65
392
1.74
3.97
1.6
1.8
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
51
287
1.85
3.91
1.4
1.3
au/ml
45.1
37.2
—
6
17
(3014111) Lactate [Moles/volume] in Serum or Plasma
55
318
1.80
3.87
5.1
7.1
mmol/l
1.3
1.2
0.32
55
310
(42529406) Shigella sp [Presence] in Stool by Culture
28
127
2.26
3.82
1.1
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
511
4723
1.58
3.71
16.9
11.8
%
41.0
40.2
3.67
437
3716
(3002256) Pathology report gross observation
95
644
1.57
3.69
1.2
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
393
3464
1.40
3.60
3.7
2.8
u/l
45.1
46.9
0.20
372
3289
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
32
158
2.08
3.57
4.2
2.8
mmol/l
25.0
24.0
0.81
27
147
(3014576) Chloride [Moles/volume] in Serum or Plasma
72
462
1.64
3.51
4.9
6.9
mmol/l
104.7
104.4
0.17
72
446
(3025941) Bacteria identified in Stool by Culture
44
245
1.86
3.51
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
27
126
2.20
3.47
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
27
126
2.20
3.47
1.1
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
101
710
1.51
3.32
3.1
2.9
mmol/l
2.4
2.4
1.12
84
637
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
63
398
1.65
3.27
4.6
4.8
u/l
222.6
241.7
1.01
58
380
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
29
143
2.08
3.26
3.5
2.0
%
167.2
186.1
0.82
29
137
(3010726) Horse dander IgE Ab [Units/volume] in Serum
20
84
2.43
3.26
1.0
1.0
u/ml
0.7
3.5
—
7
21
(3015377) Calcium [Moles/volume] in Serum or Plasma
185
1465
1.38
3.20
3.6
3.5
mmol/l
2.3
2.4
0.68
165
1316
(3023430) Cat dander IgE Ab [Units/volume] in Serum
17
67
2.58
3.15
1.0
1.1
u/ml
1.3
4.5
—
8
23
(3000570) Elastase.pancreatic [Mass/mass] in Stool
24
112
2.19
3.10
1.3
1.4
ug/g
246.0
290.9
0.47
12
65
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
537
5064
1.62
3.08
4.6
4.0
mmol/l
4.8
4.8
0.26
512
4747
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
10
29
3.49
3.06
1.2
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
113
2.17
3.04
2.1
1.9
g/l
10.4
10.5
0.08
24
103
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
535
5044
1.60
3.03
4.6
4.0
mmol/l
1.5
1.5
2.84
508
4702
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
520
4876
1.53
2.97
4.0
3.6
mmol/l
1.3
1.3
0.83
487
4528
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
542
5130
1.63
2.97
5.1
4.4
mmol/l
2.9
2.9
0.12
512
4782
(3000991) Gas panel - Venous blood
48
292
1.70
2.88
7.1
8.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
117
2.10
2.81
2.2
1.9
g/l
3.0
3.0
0.09
24
97
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
21
97
2.21
2.80
1.1
1.1
u/ml
1.2
3.0
0.56
13
36
(3021960) Folate [Moles/volume] in Serum or Plasma
119
893
1.42
2.79
1.5
1.4
nmol/l
21.8
21.5
0.07
99
766
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
6
8.39
2.75
1.6
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
17
72
2.40
2.75
2.1
1.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
164
1305
1.35
2.69
3.0
3.2
mmol/l
8.2
7.7
0.85
134
1116
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
17
73
2.37
2.67
1.0
1.0
u/ml
1.8
1.7
—
7
41
(3045414) Leukocytes [Presence] in Urine
33
184
1.84
2.67
2.4
1.6
—
—
—
0
0
(1002224) Polysomnography panel
44
268
1.69
2.65
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
13
49
2.69
2.64
1.4
1.9
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
15
61
2.50
2.64
2.2
1.4
%
60.4
65.7
0.46
15
61
(3014133) Dog dander IgE Ab [Units/volume] in Serum
17
74
2.34
2.60
1.0
1.0
u/ml
0.5
3.1
—
7
23
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
24
121
2.02
2.59
1.5
1.2
u/ml
26.6
10.4
—
5
23
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
122
2.01
2.54
2.2
1.9
g/l
3.5
3.7
0.53
24
95
(3003327) Ova and parasites identified in Stool by Light microscopy
30
165
1.86
2.54
2.0
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
124
953
1.38
2.52
2.6
3.0
ng/l
508.5
894.7
1.57
103
796
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
123
1.99
2.49
2.2
1.9
g/l
6.7
7.2
0.99
24
102
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
123
1.99
2.49
2.2
1.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
245
2089
1.29
2.43
3.2
2.5
ug/l
95.8
109.1
0.57
234
1944
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
10
34
2.97
2.42
1.4
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
34
2.97
2.42
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
34
2.97
2.42
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
34
2.97
2.42
1.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
19
90
2.15
2.41
1.0
1.1
u/ml
0.8
6.6
—
10
42
(3013512) EKG study
150
1198
1.34
2.38
3.8
3.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
18
84
2.18
2.37
1.0
1.1
u/ml
0.6
4.6
—
9
31
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
125
973
1.36
2.35
2.1
1.9
mg/l
2.5
3.0
2.28
111
833
(3022145) Colonoscopy Study observation
72
509
1.47
2.32
1.3
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
35
2.89
2.31
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
35
2.89
2.31
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
35
2.89
2.31
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
31
178
1.78
2.31
2.1
2.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
15
66
2.31
2.26
2.0
2.7
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
14
60
2.37
2.23
1.0
1.0
u/ml
0.4
0.9
—
6
13
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
59
404
1.51
2.23
2.8
2.1
g/l
0.3
0.2
3.17
59
385
(3013247) Albumin in CSF/Albumin in Serum or Plasma
5
9
5.59
2.21
1.0
1.1
mg/g
5.2
6.4
—
5
9
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
25
136
1.88
2.21
2.5
2.2
g/l
3.4
3.8
0.96
25
129
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
13
54
2.44
2.21
5.4
6.0
u/ml
330.1
70.9
—
5
17
(3022217) INR in Platelet poor plasma by Coagulation assay
62
430
1.49
2.21
23.3
15.5
inr
1.1
1.2
0.20
11
68
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
41
259
1.63
2.18
1.1
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
14
4.32
2.15
5.8
3.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
54
367
1.52
2.12
2.5
2.9
%
1.9
1.8
0.47
49
339
(3032773) Endomysium IgG Ab [Titer] in Serum
12
49
2.48
2.11
1.0
1.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
46
302
1.57
2.10
4.9
3.5
ng/l
90.8
76.6
0.40
39
275
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
10
5.03
2.07
1.0
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
71
513
1.44
2.06
6.3
5.4
mmol/l
1.0
1.0
0.07
65
484
(3009214) Lutropin [Units/volume] in Serum or Plasma
23
125
1.87
2.05
1.2
1.3
u/l
9.5
12.7
0.56
18
99
(3023511) Choriogonadotropin [Units/volume] in Urine
19
97
1.99
2.02
1.4
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
38
2.66
2.02
1.1
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
31
186
1.70
2.01
2.2
3.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
16
3.78
1.94
2.0
1.9
nmol/l
134.0
153.3
—
6
16
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
74
547
1.40
1.91
1.2
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
186
2171
0.79
1.89
2.6
2.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
8
28
2.88
1.86
1.6
1.4
%
12.3
11.7
—
8
28
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
26
152
1.74
1.86
1.5
1.8
g/l
1.4
1.4
0.02
21
131
(3012516) Albumin [Mass/volume] in Urine
146
1200
1.29
1.86
3.0
3.4
mg/l
15.4
268.4
1.66
81
763
(36660697) Celiac disease serology panel - Serum
57
404
1.45
1.85
1.1
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
144
1183
1.29
1.84
3.2
2.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
110
872
1.32
1.83
3.9
3.1
kg/l
1.0
1.0
1.20
14
129
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
73
2.08
1.82
1.1
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
35
2.60
1.80
3.3
3.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
35
224
1.60
1.80
2.9
2.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
44
298
1.51
1.78
1.7
1.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
30
2.69
1.73
1.0
1.1
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
34
219
1.59
1.72
5.6
10.5
%
1.2
1.3
0.20
34
219
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
48
2.32
1.71
1.3
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
11
48
2.32
1.71
1.3
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
118
954
1.30
1.70
4.8
4.1
ug/l
1.8
2.2
0.44
106
858
(3002032) Base excess in Venous blood by calculation
46
318
1.48
1.70
3.6
2.9
mmol/l
2.1
1.9
0.13
37
253
(3004716) Salmonella sp identified in Stool by Organism specific culture
39
261
1.53
1.68
1.4
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
31
2.60
1.66
9.0
9.7
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
15
76
2.00
1.65
1.2
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
15
76
2.00
1.65
1.2
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
49
2.27
1.64
1.3
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
49
2.27
1.64
1.7
1.4
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
5
14
3.59
1.62
7.0
2.5
%
111.4
127.6
—
5
14
(40761535) Cells panel - Urine sediment
40
272
1.50
1.61
3.0
3.0
—
—
—
0
0
(44813793)
8
32
2.52
1.60
1.0
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
162
1372
1.25
1.60
1.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
28
178
1.60
1.51
1.7
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
51
2.18
1.51
1.3
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
51
2.18
1.51
1.3
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
51
2.18
1.51
1.3
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
23
139
1.68
1.50
1.5
1.6
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
33
221
1.52
1.44
5.7
10.4
%
0.8
0.6
0.68
33
221
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
16
3.14
1.44
1.2
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
16
3.14
1.44
1.2
1.8
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
22
2.74
1.43
8.0
2.0
%
98.0
112.0
—
6
22
(3022621) pH of Urine by Test strip
39
271
1.47
1.43
2.4
2.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
54
399
1.39
1.43
4.9
8.4
mmol/l
0.8
1.3
0.40
43
331
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
79
620
1.32
1.43
2.2
1.8
%
1.5
1.4
0.41
68
561
(3000492) Spirometry study
68
525
1.33
1.38
1.5
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
44
316
1.42
1.37
2.6
2.7
e9/l
3.6
4.2
0.76
33
265
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
196
1721
1.21
1.35
3.5
2.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
38
267
1.45
1.34
2.6
3.3
e9/l
73.6
71.1
0.23
27
202
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
52
388
1.37
1.32
1.3
1.2
iu/ml
78.0
140.8
1.59
15
171
(3028026) IgM [Mass/volume] in Serum or Plasma
38
269
1.44
1.29
2.8
1.8
g/l
1.2
1.4
0.50
38
254
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
17
99
1.74
1.28
1.1
1.2
mmol/l
3.7
3.7
0.05
17
94
(44816559) Phosphatidylethanol [Mass/volume] in Blood
17
99
1.74
1.28
1.2
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
15
84
1.81
1.28
1.2
1.2
u/ml
2.3
4.8
—
7
28
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
55
2.02
1.28
2.3
2.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
25
162
1.57
1.28
4.3
3.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
147
1265
1.22
1.24
3.7
4.1
mg/mmol
1.9
7.7
7.89
82
798
(4094501)
19
116
1.66
1.22
1.2
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
5
19
2.64
1.22
2.2
1.4
%
22.6
37.9
—
5
11
(21494434) Karyotype in Bone marrow
6
26
2.32
1.19
1.0
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
8
38
2.12
1.18
1.0
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
71
567
1.29
1.16
3.0
2.6
ug/l
0.6
0.7
0.39
50
348
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
20
2.51
1.15
4.0
3.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
32
225
1.45
1.14
4.0
3.4
kpa
5.2
5.2
0.11
32
211
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
36
0.00
1.14
0.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
80
1.77
1.13
1.1
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
80
1.77
1.13
1.1
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
73
1.80
1.11
1.2
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
31
2.27
1.10
2.1
2.0
—
—
—
0
0
(4010399)
40
296
1.38
1.09
1.4
1.4
—
—
—
0
0
(4062490)
8
41
1.96
1.09
1.1
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
38
279
1.39
1.09
1.9
2.3
ug/l
17.8
7.0
0.41
33
255
(3016244) Insulin [Units/volume] in Serum or Plasma
7
32
2.20
1.08
4.9
3.1
mu/l
79.5
20.5
—
7
32
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
137
1.55
1.07
1.3
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
49
628
0.76
1.05
1.6
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
15
90
1.68
1.05
1.4
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
19
122
1.58
1.03
2.6
2.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
11
60
1.85
1.03
1.3
1.3
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
7
34
2.07
1.03
1.0
1.1
mg/l
39.0
36.7
—
7
28
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
32
231
1.41
1.02
1.4
1.6
—
—
—
0
0
(4268621)
10
53
1.90
1.01
2.1
2.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
91
1.67
1.01
1.2
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
105
894
1.21
0.99
1.8
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
22
148
1.51
0.99
1.7
1.8
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
23
2.18
0.98
1.4
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
16
100
1.62
0.97
2.4
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
24
166
1.46
0.96
1.8
1.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
66
537
1.26
0.95
1.8
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
26
184
1.43
0.93
1.5
1.4
miu/ml
296.1
233.9
0.30
11
88
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
52
1.74
0.92
1.0
1.1
—
—
—
0
0
(4306422)
13
78
1.68
0.92
1.2
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
28
2.15
0.91
1.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
26
185
1.42
0.91
1.9
1.9
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
5
104
0.48
0.89
2.2
7.6
mmol/l
1.7
1.3
—
5
95
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
29
2.08
0.89
1.0
1.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
76
634
1.23
0.89
1.6
1.7
nmol/l
1033.3
1182.0
0.57
57
481
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
43
1.87
0.87
1.0
1.1
—
—
—
0
0
(4024509)
8
43
1.87
0.87
2.0
1.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
44
344
1.30
0.87
4.8
9.3
%
96.1
96.4
0.19
44
338
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
69
571
1.24
0.87
4.8
3.9
%
30.5
32.1
0.73
49
393
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
30
2.01
0.87
1.2
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
6
31
1.94
0.84
1.2
2.5
—
41.5
—
0
12
(3020779) Urea [Moles/volume] in Serum or Plasma
43
337
1.30
0.84
8.5
7.3
mmol/l
9.0
8.4
0.22
43
319
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
33
430
0.75
0.82
1.3
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
46
1.75
0.82
1.0
1.4
—
—
—
0
0
(3016750) Collection duration of Urine
0
24
0.00
0.79
0.0
1.8
—
484.2
—
0
12
(3027944) Amphetamines [Presence] in Urine
25
182
1.39
0.79
1.7
1.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
27
0.00
0.77
0.0
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
19
132
1.45
0.77
2.4
3.7
g/l
0.2
0.2
—
9
57
(3004775) Volume in Urine collected for unspecified duration
0
28
0.00
0.76
0.0
1.9
—
533.9
—
0
13
(3000764) Benzodiazepines [Presence] in Urine
25
184
1.37
0.75
1.9
1.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
125
1110
1.16
0.75
3.8
3.1
estimate
0.0
0.0
0.80
44
405
(3016879) Cocaine [Presence] in Urine
23
167
1.39
0.74
2.0
1.9
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
38
1.85
0.73
1.1
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
20
142
1.42
0.73
1.6
2.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
25
2.01
0.73
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
25
2.01
0.73
1.0
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
117
1.47
0.72
2.1
2.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
40
1.76
0.71
1.4
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
57
1.59
0.71
2.0
2.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
25
186
1.36
0.71
1.9
1.8
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
26
1.93
0.70
3.6
2.2
%
99.8
105.1
—
5
26
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
57
475
1.22
0.70
6.9
5.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
19
135
1.42
0.70
1.9
2.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
10
61
1.65
0.69
2.7
2.0
u/ml
9.1
3.3
—
10
56
(4027681)
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
64
542
1.20
0.67
1.7
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
113
1007
1.15
0.65
1.5
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
88
771
1.17
0.64
3.7
3.5
%
19.3
21.1
0.67
38
332
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
71
1.56
0.62
1.1
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
52
1.55
0.59
1.5
1.8
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
14
97
1.45
0.59
4.0
3.6
—
1.3
—
0
10
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
8
53
1.52
0.58
1.3
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
35
1.72
0.58
2.2
1.5
—
—
—
0
0
(4146454)
6
35
1.72
0.58
1.8
3.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
83
731
1.16
0.57
1.7
1.6
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
6
36
1.67
0.57
1.2
1.1
nmol/l
1.0
1.6
—
6
31
(3002173) Hemoglobin [Mass/volume] in Arterial blood
40
330
1.23
0.56
5.1
9.5
g/l
128.7
120.5
1.45
40
322
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
90
1.45
0.56
2.1
1.7
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
6
37
1.63
0.55
1.2
1.3
mmol/l
1.6
1.9
—
6
37
(3006270) Folate [Moles/volume] in Blood
6
38
1.58
0.54
1.0
1.1
nmol/l
392.7
433.5
—
6
32
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
17
125
1.37
0.54
1.5
1.7
—
76.7
—
0
6
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
64
1.41
0.51
1.1
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
11
75
1.48
0.51
1.9
1.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
41
1.47
0.50
5.5
3.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
84
1.44
0.49
1.2
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
45
1.56
0.49
1.0
1.2
—
—
—
0
0
(3020891) Body temperature
16
119
1.35
0.48
3.3
5.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
74
656
1.15
0.48
1.4
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
46
1.53
0.48
4.1
3.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
27
332
0.80
0.48
4.1
4.4
%
0.8
0.4
—
5
70
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
37
440
0.83
0.48
2.7
4.6
ug/l
3.0
17.8
0.83
27
342
(3019225) pH of Specimen
47
402
1.18
0.48
4.9
4.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
121
1108
1.12
0.48
4.4
4.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
47
1.50
0.47
1.0
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
42
358
1.19
0.45
1.4
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
197
0.76
0.44
1.7
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
23
184
1.26
0.44
1.2
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
41
350
1.18
0.43
2.4
2.3
ml/min/173m2
72.2
68.1
0.49
20
134
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
10
70
1.44
0.42
1.8
1.6
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
10
70
1.44
0.42
2.2
2.8
kpa
8.8
8.1
—
10
64
(3017704) Immunofixation for Urine
0
16
0.00
0.41
0.0
2.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
16
123
1.31
0.41
2.1
2.3
ug/l
144.1
397.2
1.74
16
116
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
2.3
—
2.8
—
0
7
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
17
0.00
0.40
0.0
2.8
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
8
60
1.34
0.40
1.3
1.4
ug/l
2.1
6.0
—
8
53
(3004451) EKG impression Narrative
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
62
552
1.14
0.40
1.9
1.8
—
—
—
0
0
(4281824)
8
61
1.32
0.39
1.4
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
78
860
0.89
0.39
1.4
1.6
pmol/l
407.0
19113993.3
0.79
65
722
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
1681.1
—
0
19
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
19
0.00
0.39
0.0
1.0
—
32.8
—
0
19
(1617658) Protocol used for examination of sentinel lymph nodes
9
66
1.37
0.38
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
43
374
1.16
0.38
1.5
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
12
158
0.75
0.37
1.1
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
39
449
0.86
0.37
1.8
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
17
134
1.28
0.37
2.8
2.7
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
10
135
0.74
0.36
1.4
6.2
%
1.2
1.6
—
10
130
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
81
1.36
0.36
1.1
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
90
1.34
0.36
1.2
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
25
208
1.21
0.36
1.8
1.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
79
0.63
0.35
2.6
2.6
—
586.5
—
0
8
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
48
424
1.14
0.35
2.4
2.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
45
1.34
0.34
1.5
3.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
127
1.27
0.34
1.1
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
16
127
1.27
0.34
1.1
1.2
—
71.8
—
0
11
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
46
1.31
0.33
1.3
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
46
1.31
0.33
1.3
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
46
1.31
0.33
1.3
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
20
164
1.23
0.33
1.5
2.1
u/l
2650.0
2527.8
—
5
71
(1761482) Bacteria [#/volume] in Urine by Culture
7
100
0.70
0.31
2.4
3.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
54
1.30
0.30
1.1
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
19
158
1.21
0.28
1.6
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
76
1.32
0.28
6.9
4.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
12
94
1.28
0.28
2.0
5.2
mmol/l
3.8
3.9
0.18
12
84
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
8
66
1.21
0.27
1.0
1.1
g/l
1.5
1.5
—
8
59
(1616796) Gas panel - Central venous blood
9
75
1.20
0.25
1.7
2.8
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
16
133
1.21
0.24
2.3
1.6
g/l
1.2
1.2
0.14
16
124
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
94
0.74
0.22
1.3
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
40
1.25
0.22
3.0
3.0
nmol/l
2.5
136.2
—
5
40
(3005570) Glucose [Moles/volume] in Urine
5
40
1.25
0.22
1.6
2.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
42
1.19
0.21
1.2
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(4133840)
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
10
0.00
0.21
0.0
7.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
10
0.00
0.21
0.0
3.6
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
10
0.00
0.21
0.0
1.6
—
6.0
—
0
5
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.3
—
93.9
—
0
7
(40758292) HTLV I+II Ab panel - Serum
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
51
1.18
0.19
3.3
1.6
g/l
0.9
1.0
—
6
51
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
51
1.18
0.19
1.0
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
90
1.23
0.19
1.1
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
33
363
0.90
0.19
5.2
4.4
%
0.7
1.0
—
7
104
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
53
1.13
0.18
1.2
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
20
227
0.88
0.18
1.3
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
23
204
1.13
0.18
1.8
5.9
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
59
1.19
0.18
1.7
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
133
1279
1.05
0.18
2.9
2.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
119
1.18
0.18
1.1
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
60
1.17
0.18
1.3
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
72
1.11
0.16
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
203
0.88
0.15
1.4
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
35
379
0.92
0.15
3.5
3.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
140
0.85
0.15
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
140
0.85
0.15
1.5
1.4
—
—
—
0
0
(4034850)
16
140
1.15
0.15
7.9
6.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
93
1.19
0.14
1.2
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
139
0.86
0.14
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
139
0.86
0.14
1.5
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
84
1.19
0.14
1.7
2.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
10
84
1.19
0.14
3.4
3.5
umol/l
33.8
35.3
—
10
77
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
84
1.19
0.14
5.2
2.6
e9/l
3.1
3.9
—
10
84
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
109
0.82
0.13
1.3
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
21
190
1.11
0.13
4.1
10.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
51
483
1.06
0.12
1.7
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
22
240
0.91
0.11
1.2
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
14
125
1.12
0.10
2.4
1.7
g/l
0.2
0.2
0.89
14
118
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
13
145
0.89
0.09
1.5
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
55
1.09
0.09
1.0
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
57
1.05
0.08
2.7
2.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
63
0.79
0.08
1.0
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
32
338
0.94
0.08
4.2
4.5
%
0.2
0.1
—
6
92
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
88
1.14
0.08
5.2
2.8
%
54.2
55.9
—
10
88
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
70
0.86
0.07
1.0
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
75
0.80
0.07
1.0
1.7
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
8
74
1.08
0.07
1.1
2.8
kpa
4.9
5.0
—
8
74
(3027315) Oxygen [Partial pressure] in Blood
8
74
1.08
0.07
1.1
2.8
kpa
8.3
8.9
—
8
74
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
76
1.05
0.07
1.3
1.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
18
194
0.93
0.07
3.4
9.2
mmol/l
25.4
25.0
0.21
18
188
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
85
0.82
0.07
1.4
1.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
94
0.85
0.06
2.0
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
102
0.88
0.06
1.3
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
102
0.88
0.06
1.1
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
105
0.85
0.06
1.3
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
119
1.09
0.06
1.5
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
13
139
0.93
0.03
1.5
2.1
iu/l
4.9
6.0
—
5
54
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
31
318
0.97
0.02
3.8
2.7
u/ml
35.7
49.8
0.26
31
308
(4035726)
44
448
0.98
0.01
1.3
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
12
114
1.05
0.00
1.5
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
115
1.04
0.00
1.5
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
25
255
0.98
0.00
1.8
1.8
mg/l
3.5
2.9
0.26
20
186
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
143
0.98
0.00
1.4
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
102
0.98
0.00
1.1
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
54
0.93
0.00
1.0
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
52
0.96
0.00
1.0
2.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
59
1.02
0.00
1.2
1.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
68
0.88
0.00
1.2
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
1.7
—
0
5
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.7
—
49.1
—
0
7
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
72
0.97
0.00
1.0
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
9
0.00
0.00
0.0
2.4
—
54.9
—
0
9
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
74
0.95
0.00
1.0
1.6
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
74
0.95
0.00
1.4
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
79
0.88
0.00
2.9
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
9
0.00
0.00
0.0
3.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
9
0.00
0.00
0.0
1.3
—
3.6
—
0
9
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
25
250
1.00
0.00
1.6
2.8
ng/l
82.3
164.4
1.85
20
229
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
5.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
1.6
—
0
7
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
5.1
—
0.1
—
0
8
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
6
0.00
-0.00
0.0
5.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
3.3
—
20.2
—
0
8
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
-0.00
0.0
4.5
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
8
0.00
-0.00
0.0
1.8
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
-0.00
0.0
8.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_PERONEALTEND and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_PERONEALTEND | 0.781 [0.6, 1.01] | 0.059 |
| Birth year | 0.994 [0.98, 1.01] | 0.318 |
During the follow-up period (1.1.1998 — 31.12.2019), 64 out of 1548 females with M13_PERONEALTEND died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_PERONEALTEND | 0.976 [0.75, 1.27] | 0.857 |
| Birth year | 0.984 [0.97, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 67 out of 851 males with M13_PERONEALTEND died.
Mortality risk
Mortality risk for people of age
years, who have M13_PERONEALTEND.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.071% | 0.197% |
| 5 | 0.451% | 1.111% |
| 10 | 1.115% | 2.495% |
| 15 | 2.087% | 4.866% |
| 20 | 3.869% | 8.416% |
Relationships between endpoints
↥Index endpoint: M13_PERONEALTEND – Peroneal tendinitis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data